RxDoctor Payments Data

Kelsi Sawatzky, OD

Optometrist · West Des Moines, IANPI 1245768076

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 82.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $11,500 and has fallen 78.3% since, to $2,500 in 2025. Among optometrist clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,594in general payments, 2019–2025

Across 155 payments — averaging $165.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$21K
  • Alcon$3K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
  • Johnson & Johnson Vision Care, Inc.$84
  • Tarsus Pharmaceuticals, Inc.$75
  • AbbVie$44
  • plus $44 from 2 others

What the payments were for

  • Consulting fees$2,89011%
  • Speaking & faculty fees$11,93547%
  • Travel & lodging$7,07428%
  • Food & beverage$3,69514%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,594 in reported general payments places this provider in the 95th percentile of 559 optometrist providers in Iowa.

See all optometrist providers in Iowa

Medicare billing

Part B allowed, 2024
$14,197
Medicare patients
89
Services billed
175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XiidraLifitegrast11$15,827
Latanoprost58$206
Timolol Maleate11$50

Paid to pharmacies, not to this prescriber.

Other optometrist in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →